Agonist-dependent consequences of proline to alanine substitution in the transmembrane helices of the calcitonin receptor

British Journal of Pharmacology

Volumn 151, Issue 5, 2007, Pages 678-687

  Bailey, R J ^a   Hay, D L ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Calcitonin; Calcitonin receptor; Transmembrane proline residue

Indexed keywords

ALANINE; CALCITONIN; CALCITONIN RECEPTOR; CYCLIC AMP; POLYETHYLENEIMINE; PROLINE; SALCATONIN;

AGONIST; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; BINDING COMPETITION; CELL STRAIN COS7; CELL SURFACE; CONTROLLED STUDY; CYCLIC AMP RESPONSIVE ELEMENT; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSFECTION; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR BINDING; SITE DIRECTED MUTAGENESIS; WHOLE CELL; WILD TYPE;

ALANINE; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; AMYLOID; ANIMALS; BLOTTING, WESTERN; CALCITONIN; CELLS, CULTURED; CYCLIC AMP; DNA; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE POTENTIALS; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PROLINE; RADIOLIGAND ASSAY; RECEPTORS, CALCITONIN; SALMON; TRANSFECTION;

EID: 34347349008     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0707246     Document Type: Article

References (21)

1. Bailey RJ, Hay DL (2006). Pharmacology of the human CGRP1 receptor in Cos 7 cells. Peptides 27: 1367-1375.
2. Bisello A, Chorev M, Rosenblatt M, Monticelli L, Mierke DF, Ferrari SL (2002). Selective ligand-induced stabilization of active and desensitized parathyroid hormone type 1 receptor conformations. J Biol Chem 277: 38524-38530.
3. Castro M, Nikolaev VO, Palm D, Lohse MJ, Vilardaga J-P (2005). Turn-on switch in parathyroid hormone receptor by a two-step parathyroid hormone binding mechanism. Proc Natl Acad Sci USA 102: 16084-16089.
4. Conner AC, Hay DL, Simms J, Howitt SG, Schindler M, Smith DM et al. (2005). A key role for transmembrane prolines in calcitonin receptor-like receptor agonist binding and signalling: implications for family B G-protein-coupled receptors. Mol Pharmacol 67: 20-31.
5. Dong M, Pinon DI, Cox RF, Miller LJ (2004). Molecular approximation between a residue in the amino-terminal region of calcitonin and the third extracellular loop of the class B G protein-coupled calcitonin receptor. J Biol Chem 279: 31177-31182.
6. Gether U (2000). Uncovering molecular mechanisms involved in activation of G protein-coupled Receptors. Endocr Rev 21: 90-113.
7. 2 adrenoceptor. EMBO J 16: 6737-6747.
8. Hilton JM, Dowton M, Houssami S, Sexton PM (2000). Identification of key components in the irreversibility of salmon calcitonin binding to calcitonin receptors. J Endocrinol 166: 213-226.
9. Hoare SRJ (2005). Mechanisms of peptide and nonpeptide ligand binding to Class B G-protein-coupled receptors. Drug Discovery Today 10: 417-427.
10. Houssami S, Findlay DM, Brady CL, Myers DE, Martin TJ, Sexton PM (1994). Isoforms of the rat calcitonin receptor: consequences for ligand binding and signal transduction. Endocrinol 135: 183-190.
11. Knudsen SM, Tams JW, Fahrenkrug J (2001). Functional roles of conserved transmembrane prolines in the human VPAC1 receptor. FEBS Lett 503: 126-130.
12. Michelangeli VP, Findlay DM, Moseley JM, Martin TJ (1983). mechanisms of calcitonin induction of prolonged activation of adenylate cyclase in human cancer cells. J Cyclic Nucleotide Protein Phosphorylation Res 9: 129-141.
13. Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA et al. (2000). Crystal structure of rhodopsin: a G protein-coupled receptor. Science 289: 739-745.
14. Pham V, Dong M, Wade JD, Miller LJ, Morton CJ, Ng H et al. (2005). Insights into interactions between the \{alpha\}-helical region of the salmon calcitonin antagonists and the human calcitonin receptor using photoaffinity labeling. J Biol Chem 280: 28610-28622.
15. Pham V, Wade JD, Purdue BW, Sexton PM (2004). Spatial proximity between a photolabile residue in position 19 of salmon calcitonin and the amino terminus of the human calcitonin receptor. J Biol Chem 279: 6720-6729.
16. Poyner DR, Sexton PM, Marshall I, Smith DM, Quirion R, Born W et al. (2002). International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacol Rev 54: 233-246.
17. Sexton PM, Findlay DM, Martin TJ (1999). Calcitonin. Curr Med Chem 6: 1067-1093.
18. Stitham J, Martin KA, Hwa J (2002). The critical role of transmembrane prolines in human prostacyclin receptor activation. Mol Pharmacol 61: 1202-1210.
19. Watson C, Chen G, Irving P, Way J, Chen WJ, kenakin T (2000). The use of stimulus-biased assay systems to detect agonist-specific receptor active states: implications for the trafficking of receptor stimulus by agonists. Mol Pharmacol 58: 1230-1238.
20. Versteeg HH, Nijhuis E, Van Der Brink GR, Evertzen M, Pynaert GN, Van Deventer SJ et al. (2000). A new phosphospecific cell-based ELISA for p42/p44 mitogen-activated protein kinase (MAPK), p38 MAPK, protein kinase B and cAMP-response-element-binding protein. Biochem J 350: 717-722.
21. Yohannan S, Faham S, Yang D, Whitelegge JP, Bowie JU (2004). The evolution of transmembrane helix kinks and the structural diversity of G protein-coupled receptors. Proc Natl Acad Sci 101: 959-963.